Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice.

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding Financial support was supported by the National Natural Science Foundation of China (Nos. 81772477, 81201848, 82173684, 82204181 and 82270104); Fundamental Research Program of Shanxi Province (No. 202303021221192); high level key discipline construction project of the National Administration of Traditional Chinese Medicine-Resource Chemistry of Chinese Medicinal Materials (No.zyyzdxk-2023083); the Key R&D Program of Jiangsu Province (No. BE2023840); Nanjing University of Chinese Medicine National Natural Science Foundation of China Counterpart Funding (No. XPT82204181); Jiangsu Provincial Health Commission (No. Z2021057) and Young Doctors' Innovation and Development Program (No. HXQNJJ-2023-010)."